Delivery Order SPE2DB25D3202-SPE2DB25FTBFD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,340.27 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of August 11, 2025. This non-competitive, firm fixed-price delivery order was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,716.90 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitive, firm fixed-price delivery order, valued at $1,079.68, was executed on July 25, 2025, with completion targeted for July 28, 2025. The contract does not carry a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with a ceiling value of $1,288.20 and an ultimate completion date of August 18, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,451.00 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 44 MCG 10.6GM inhalers. This contract, which was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order executed without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $4,875.39 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This contract employs firm fixed price pricing and was competitively awarded without a set-aside designation. The order was placed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,055.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, just three days after the award date of July 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBFDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,192.98 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of August 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including products for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Fluticasone propionate order represents a routine medical supply delivery under this established contract vehicle designed to ensure consistent availability of critical medications across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/25/25 |